SEARCH

SEARCH BY CITATION

References

  • Aggarwal, B.B., Singh, S., LaPushin, R. & Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Letters, 364, 58.DOI: 10.1016/0014-5793(95)00339-b
  • Amenomori, T., Tomonaga, M., Jinnai, I., Soda, H., Nonaka, H., Matsuo, T., Yoshida, Y., Kuriyama, K., Ichimaru, M. & Suematsu, T. (1987) Cytogenetic and cytochemical studies on progenitor cells of primary acquired sideroblastic anemia (PASA): involvement of multipotent myeloid stem cells in PASA clone and mosaicism with normal clone. Blood, 70, 13671372.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. & The French-American-British (FAB) Group (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Björkman, S.E. (1956) Chronic refractory anemia with sideroblastic bone marrow. A study of four cases. Blood, 11, 250259.
  • Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F. & Fontenay-Roupie, M. (1997) Fas (CD 95 / APO-1) expression and apoptosis in myelodysplasia. Leukemia, 11, 839845.
  • Bröker, S., Meunier, B., Rich, P., Gattermann, N. & Hofhaus, G. (1998) MtDNA mutations associated with sideroblastic anemia cause a defect of mitochondrial cytochrome c oxidase. European Journal of Biochemistry, 258, 132138.
  • Cazzola, M., Andersson, J., Ganser, A. & Hellström-Lindberg, E. (1998) A patient-oriented approach to treatment of myelodysplastic syndromes. Haematologica, 83, 910935.
  • Clark, D.M. & Lampert, I.A. (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis. Leukemia and Lymphoma, 2, 415418.
  • DeMaria, R., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S.M., Alnemri, E.S., Testa, U. & Peschle, C. (1999a) Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature, 401, 489492.DOI: 10.1038/46809
  • DeMaria, R., Testa, U., Luchetti, L., Zeuner, A., Stassi, G., Pelosi, E., Riccioni, R., Felli, N., Samoggia, P. & Peschie, C. (1999b) Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood, 93, 796803.
  • Dhein, J., Walczak, H., Bäumler, C., Debatin, K.M. & Krammer, P.H. (1995) Autocrine T-cell suicide mediated by APO-1 / (Fas / CD95). Letters to Nature, 373, 438441.
  • Fadeel, B., Hassan, Z., Hellström-Lindberg, E., Henter, J.I., Orrenius, S. & Zhivotovsky, B. (1999a) Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia, 13, 719728.
  • Fadeel, B., Orrenius, S. & Zhivotovsky, B. (1999b) Apoptosis in human disease: a new skin for the old ceremony? Biochemical Biophysical Research Communications, 266, 699717.
  • Faleiro, L., Kobayashi, R., Fearnhead, H. & Lazebnik, Y. (1997) Multiple species of CPP32 and Mch are the major active caspases present in apoptotic cells. EMBO Journal, 16, 22712281.
  • Fontenay-Roupie, M., Bouscary, D., Guesnu, M., Picard, F., Melle, J., Lacombe, C., Gisselbrecht, S., Mayeux, P. & Dreyfus, F. (1999) Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. British Journal of Haematology, 106, 464473.
  • Fulda, S., Scaffidi, C., Susin, S.A., Krammer, P.H., Kroemer, G., Peters, M.E. & Debatin, K.M. (1998) Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. Journal of Biological Chemistry, 273, 3394233948.
  • Gattermann, N. (1999) From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leukemia Research, 24, 141151.
  • Gattermann, N., Aul, C. & Schneider, W. (1990) Two types of acquired sideroblastic anaemia (AISA). British Journal of Haematology, 74, 4552.
  • Gattermann, N., Retzlaff, S., Wang, Y.L., Hofhaus, G., Heinish, J., Aul, C. & Schneider, W. (1997) Heteroplasmic point mutation of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired sideroblastic anemia. Blood, 90, 49614972.
  • Gersuk, G.M., Beckham, C., Loken, M.R., Kiener, P., Anderson, J. & Farrand, A. (1998) A role for tumour necrosis factor-alpha, fas and fas-ligand in marrow failure associated with myelodysplastic syndrome. British Journal of Haematology, 103, 176188.
  • Greenberg, P.L. (1994) The myelodysplastic syndromes. In: Hematology: Basic Principles and Practice, 2nd edn (ed. by R.Hoffman, E.Benz, S.Shattil, B.Furie & H.Cohen, pp. 10981121. Churchill Livingstone, New York.
  • Greenberg, P.L., Cox, C., LeBeau, M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Gregoli, P.A. & Bondurant, M.C. (1999) Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. Journal of Cellular Physiology, 178, 133143.DOI: 10.1002/(sici)1097-4652(199902)178:2<133::aid-jcp2>3.0.co;2-5
  • Gupta, P., Niehans, G.A., LeRoy, Sc, Gupta, K., Morrison, V.A., Schultz, C., Knapp, D.J. & Kratzke, R.A. (1999) Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype, and predicts survival. Leukemia, 13, 4453.
  • Hellström-Lindberg, E., Kanter-Lewensohn, L. & Öst, Å. (1997) Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with Granulocyte-CSF and erythropoietin. Leukemia Research, 21, 415425.DOI: 10.1016/s0145-2126(96)00110-5
  • Hellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Löfvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J.M., Winqvist, I., Öberg, G., Österborg, A. & Öst, Å. (1998) Treatment of the anemia in myelodysplastic syndromes with granulocyte-CSF plus erythropoietin: results from a randomized phase II study and long-term follow-up on 71 patients. Blood, 92, 6875.
  • Jonasova, A., Neuwirtova, R., Cermak, J., Vozubulova, V., Mocikova, K., Siskova, M. & Hochova, I. (1998) Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. British Journal of Haematology, 100, 304309.DOI: 10.1046/j.1365-2141.1998.00551.x
  • Josefsen, D., Myklebust, J.H., Lynch, D.H., Stokke, T., Blomhoff, H.K. & Smeland, E.B. (1999) Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis. Experimental Hematology, 27, 14511459.DOI: 10.1016/s0301-472x(99)00073-9
  • Kitagawa, M., Yamaguchi, S., Takahashi, M., Tanizawa, T., Hirokawa, K. & Kamiyama, R. (1998) Localization of fas and fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia, 12, 486492.
  • Lepelley, P., Grardel, N., Erny, O., Iaru, T., Obein, V., Cosson, A. & Fenaux, P. (1998) Fas/APO-1 (CD95) expression in myelodysplastic syndromes. Leukemia and Lymphoma, 30, 307312.
  • Marley, S.B., Lewis, J.L., Davidson, R.J., Roberts, I.A.G., Dokal, I. & Goldman, J.M. (1999) Evidence for a continuous decline of haemopoietic cell function from birth: application to evaluating bone marrow function in children. British Journal of Haematology, 106, 162166.
  • Molldrem, J.J., Caples, M., Mavroudis, D., Plante, M., Young, N.S. & Barrett, A.J. (1997) Antithymocyte globulin for patients with myelodysplastic syndrome. British Journal of Haematology, 99, 699705.
  • Molldrem, J.J., Jiang, Y.Z., Stetler-Stevenson, M., Mavroudis, D., Hensel, N. & Barrett, A.J. (1998) Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. British Journal of Haematology, 102, 13141322.
  • Mundle, S.D., Parameswaran, V., Cartlidge, J.D., Pandav, D.V., Broady-Robinson, L., Gezer, S., Robin, S.G., Rifkin, E.L., Klein, M., Alston, D.E., Hernandez, B.M., Rosi, D., Alvi, S., Shetty, V.T., Gregory, V.T., Gregory, S.A. & Raza, A. (1996) Indication of an involvement of interleukin-1betaconverting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood, 88, 26402647.
  • Mundle, S.D., Ambereen, A., Cartlidge, J.D., Reza, S., Alvi, S., Showel, M.M., Mativi, Y., Shetty, V.T., Venugopal, P., Gregory, S.A. & Raza, A. (1999a) Evidence for involvement of tumor necrosis factor -α in apoptotic death of bone marrow cells of myelodysplastic syndromes. American Journal of Hematology, 60, 3647.DOI: 10.1002/(sici)1096-8652(199901)60:1<36::aid-ajh7>3.0.co;2-#
  • Mundle, S.D., Reza, S., Ali, A., Mativi, Y., Shetty, V., Venugopal, P., Gregory, S.A. & Raza, A. (1999b) Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes. Cancer Letter, 140, 201207.
  • Mundle, S.D., Mativi, B.Y., Bagagi, K., Feldman, G., Cheema, P., Gautam, U., Reza, S., Cartlidge, J.D., Venugopal, P., Shetty, V., Gregory, S., Robin, E., Rifkin, S., Shah, R. & Raza, A. (1999c) Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic syndromes. International Journal of Hematology, 70, 8390.
  • Nicholson, D.W. & Thornberry, N.A. (1997) Caspases: killer proteases. Trends in Biochemical Science, 22, 299306.
  • Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.-T., Yu, V.L. & Miller, D.K. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 3743.
  • Parker, J.E., Fishlock, K.L., Mijovic, A., Czepulkowski, B., Pagliuca, A. & Mufti, G. (1998) Low–risk myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins. British Journal of Haematology, 103, 10751082.
  • Rajapaksa, R., Ginzton, N., Rott, L.S. & Greenberg, P. (1996) Oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 42754287.
  • Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J.M., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. & Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268276.
  • Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominiquez, C. & Raza, A. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Research, 20, 891900.DOI: 10.1016/s0145-2126(96)00008-2
  • Silva, M., Richard, C., Benito, A., Sanz, C., Olalla, I. & Fernández-Luna, J.L. (1998) Expression of Bcl-X in erythroid precursors from patients with polycythemia vera. New England Journal of Medicine, 338, 564571.
  • Sloand, E.M., Young, N.S., Sato, T., Kim, S. & Maciejewski, J.P. (1998) Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine- mediated apoptosis and expansion of their proliferative potential. Experimental Hematology, 11, 10931099.
  • Stahnke, K., Hecker, S., Kohne, E. & Debatin, K.M. (1998) CD 95 (APO-1/Fas)-mediated apoptosis in cytokine-activated hematopoietic cells. Experimental Hematology, 26, 844850.
  • Suzuki, H., Asano, H., Ohashi, H., Kinoshita, T., Murate, T., Saito, H. & Hotta, T. (1999) Clonality analysis of refractory anemia with ringed sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow precursors. Leukemia, 13, 130134.